Cerus (CERS) Net Income Growth (3y) (2013 - 2026)
Cerus (CERS) Net Income Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.35 Bn | 175.06 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 128.79 Bn | 125.91 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 107.93 Bn | 98.71 Bn | 6.41 Bn | 1.93% |
| 4 | Boston Scientific | 67.82 Bn | 66.37 Bn | 3.61 Bn | 62.29% |
| 5 | Edwards Lifesciences | 48.03 Bn | 44.36 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn | 60.12% |
| 7 | GE HealthCare Technologies | 27.90 Bn | 25.62 Bn | 1.98 Bn | 2.38% |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - | - |
| 9 | Koninklijke Philips | 23.96 Bn | 20.83 Bn | 2.07 Bn | 280.49% |
| 10 | Cerus | 602.81 Mn | 522.39 Mn | 27.89 Mn | 52.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 52.77% |
| Dec 31, 2025 | 46.65% |
| Sep 30, 2025 | 86.71% |
| Jun 30, 2025 | 12.03% |
| Mar 31, 2025 | 14.35% |
| Dec 31, 2024 | -41.33% |
| Sep 30, 2024 | 38.21% |
| Jun 30, 2024 | 27.83% |
| Mar 31, 2024 | 17.82% |
| Dec 31, 2023 | 24.82% |
| Sep 30, 2023 | 19.83% |
| Jun 30, 2023 | 3.58% |
| Mar 31, 2023 | 1.70% |
| Dec 31, 2022 | -74.24% |
| Sep 30, 2022 | 22.02% |
| Jun 30, 2022 | 21.81% |
| Mar 31, 2022 | 13.21% |
| Dec 31, 2021 | 29.21% |
| Sep 30, 2021 | 4.30% |
| Jun 30, 2021 | -4.97% |